Shares

39 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$11.74 - $14.12 $6,128 - $7,370
-522 Reduced 19.48%
2,157 $28,000
Q4 2022

Jun 14, 2023

BUY
$10.01 - $13.9 $5,225 - $7,255
522 Added 24.2%
2,679 $32.5 Million
Q3 2022

Jun 14, 2023

BUY
$13.31 - $23.25 $6,947 - $12,136
522 Added 24.2%
2,679 $37.1 Million
Q2 2022

Jun 20, 2023

BUY
$15.73 - $22.91 $8,211 - $11,959
522 Added 24.2%
2,679 $50,000
Q1 2022

Jun 20, 2023

BUY
$16.95 - $21.74 $8,847 - $11,348
522 Added 24.2%
2,679 $57,000
Q1 2022

Mar 30, 2023

SELL
$16.95 - $21.74 $161,872 - $207,616
-9,550 Reduced 78.09%
2,679 $57,000
Q1 2022

May 12, 2022

SELL
$16.95 - $21.74 $161,872 - $207,616
-9,550 Reduced 78.09%
2,679 $57,000
Q4 2021

Jun 21, 2023

BUY
$17.19 - $22.84 $173,137 - $230,044
10,072 Added 466.94%
12,229 $248,000
Q3 2021

Jun 21, 2023

BUY
$22.29 - $28.7 $224,504 - $289,066
10,072 Added 466.94%
12,229 $272,000
Q2 2021

Jun 21, 2023

BUY
$22.32 - $32.07 $224,807 - $323,009
10,072 Added 466.94%
12,229 $347,000
Q2 2021

Mar 30, 2023

BUY
$22.32 - $32.07 $8,570 - $12,314
384 Added 3.24%
12,229 $347,000
Q2 2021

Aug 16, 2021

BUY
$22.32 - $32.07 $272,683 - $391,799
12,217 Added 101808.33%
12,229 $347,000
Q1 2021

Jun 26, 2023

BUY
$22.07 - $26.31 $213,814 - $254,891
9,688 Added 449.14%
11,845 $267 Million
Q1 2021

May 14, 2021

SELL
$22.07 - $26.31 $261,154 - $311,326
-11,833 Reduced 99.9%
12 $267,000
Q4 2020

Jun 22, 2023

BUY
$16.76 - $23.74 $162,370 - $229,993
9,688 Added 449.14%
11,845 $279,000
Q3 2020

Jun 26, 2023

BUY
$16.35 - $21.4 $158,398 - $207,323
9,688 Added 449.14%
11,845 $218,000
Q2 2020

Jun 26, 2023

BUY
$16.34 - $25.24 $158,301 - $244,525
9,688 Added 449.14%
11,845 $227,000
Q1 2020

Jul 12, 2023

BUY
$14.66 - $30.57 $142,026 - $296,162
9,688 Added 449.14%
11,845 $200,000
Q1 2020

Mar 30, 2023

BUY
$14.66 - $30.57 $3,386 - $7,061
231 Added 1.99%
11,845 $200,000
Q1 2020

May 15, 2020

BUY
$14.66 - $30.57 $3,386 - $7,061
231 Added 1.99%
11,845 $200,000
Q4 2019

Jul 12, 2023

BUY
$22.45 - $27.09 $212,309 - $256,190
9,457 Added 438.43%
11,614 $314,000
Q4 2019

Mar 30, 2023

SELL
$22.45 - $27.09 $12,167 - $14,682
-542 Reduced 4.46%
11,614 $314,000
Q4 2019

Feb 14, 2020

SELL
$22.45 - $27.09 $12,167 - $14,682
-542 Reduced 4.46%
11,614 $315,000
Q3 2019

Jul 12, 2023

BUY
$25.98 - $30.8 $259,774 - $307,969
9,999 Added 463.56%
12,156 $330,000
Q3 2019

Mar 30, 2023

BUY
$25.98 - $30.8 $28,759 - $34,095
1,107 Added 10.02%
12,156 $330,000
Q3 2019

Nov 14, 2019

BUY
$25.98 - $30.8 $28,759 - $34,095
1,107 Added 10.02%
12,156 $330,000
Q2 2019

Jul 12, 2023

BUY
$27.55 - $32.39 $244,974 - $288,011
8,892 Added 412.24%
11,049 $330,000
Q1 2019

Jul 13, 2023

BUY
$25.85 - $30.47 $229,858 - $270,939
8,892 Added 412.24%
11,049 $322,000
Q1 2019

Mar 30, 2023

BUY
$25.85 - $30.47 $216,364 - $255,033
8,370 Added 312.43%
11,049 $322,000
Q1 2019

May 16, 2019

SELL
$25.85 - $30.47 $87,347 - $102,958
-3,379 Reduced 23.42%
11,049 $322,000
Q1 2019

May 15, 2019

BUY
$25.85 - $30.47 $87,347 - $102,958
3,379 Added 30.58%
14,428 $2.32 Million
Q4 2018

Jul 13, 2023

BUY
$25.76 - $34.03 $229,057 - $302,594
8,892 Added 412.24%
11,049 $313,000
Q4 2018

Feb 14, 2019

BUY
$25.76 - $34.03 $217,491 - $287,315
8,443 Added 323.98%
11,049 $314,000
Q3 2018

Jul 13, 2023

BUY
$28.6 - $35.75 $254,311 - $317,889
8,892 Added 412.24%
11,049 $389 Million
Q3 2018

Nov 14, 2018

SELL
$28.6 - $35.75 $241,469 - $301,837
-8,443 Reduced 76.41%
2,606 $92,000
Q2 2018

Aug 15, 2018

BUY
$19.4 - $29.35 $8,710 - $13,178
449 Added 4.24%
11,049 $0
Q4 2017

Feb 15, 2018

BUY
$18.65 - $23.85 $197,689 - $252,810
10,600 New
10,600 $203,000
Q3 2017

Nov 14, 2017

SELL
$18.85 - $23.05 $459,299 - $561,636
-24,366 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
24,366
24,366 $486,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.25B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.